Sort
21,281 grants matching “influenza”
The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection
$827,095Joan E. Durbin · New York University School Of Medicine · U01 · FY2009 · AI
Immune Dysfunction in HIV+ Opioid Users
$827,056Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2022 · DA
Revolutionary Eilat-based Chikungunya Vaccine Vector
$825,842Tian Wang · University Of Texas Med Br Galveston · R01 · FY2021 · AI
Genetic Epidemiology of Life-Threatening Influenza in Children
$825,593Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2012 · AI
Support for the Plan of Preparation/Response against a Potential Influenza Pandem
$825,000Maria Paulina Giusti · Ministry Of Health · U51 · FY2006 · CI
5 YEAR STRATEGY FOR REDUCING MORBIDITY & MORTALITY CAUSED BY INFLUENZA
$825,000Caroline Brown · World Health Organization · U51 · FY2013 · IP
A staged strategy for pathogen discovery
$824,927W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2010 · AI
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$824,900Birjees Mazher Kazi · National Institute Of Health · U50 · FY2006 · CI
Multiplex Nucleic Acid Detection Devices for the Diagnosis of Respiratory Viruses
$824,884Robert Turner Schooley · University Of California, San Diego · U01 · FY2007 · AI
Acquisition Of A High-End, High-Speed Cell Sorter With Bio-Containment Hood
$824,680Timothy P Bushnell · University Of Rochester · S10 · FY2010 · RR
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infection
$824,595Adam Williams · Jackson Laboratory · U19 · FY2025 · AI
Public Health Epidemiology of Influenza Virus Infection and Control in China
$824,400Hong Chen · Chinese Ctr-Disease Control/Prevention · U01 · FY2019 · IP
Systems biological analyses of adaptive responses to vaccination
$824,038Rafi Ahmed · Emory University · U19 · FY2011 · AI
Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk
$823,874Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2021 · HL
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$823,763Darryl C Zeldin · Environmental Health Sciences · Z01 · FY2007 · ES
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
$823,756Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2022 · AI
Human Immunology Center at the University of Rochester
$823,655Tim Mosmann · University Of Rochester · R24 · FY2008 · AI
T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments
$823,537Aaron A Tobian · Johns Hopkins University · R01 · FY2022 · DK
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
$823,522Albert C Shaw · Yale University · R01 · FY2018 · AG
Mechanisms of CMV Replication on HIV Persistence
$823,162Sara Gianella Weibel · University Of California, San Diego · R01 · FY2022 · AI
Pulmonary pathophysiology sub-phenotypes of pneumonia
$823,005Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2023 · AI
Prenatal Factors and Risk of Schizophrenia in a Finnish National Birth Cohort
$822,929Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2011 · MH
Point of care microfluidic diagnosis system for rapid and sensitive detection of
$822,875Michel G. Bergeron · Laval University · R01 · FY2012 · AI
Development of Influenza Virus-Like Particle (VLP) Vaccines
$822,755Jose M Galarza · Technovax, Inc. · R44 · FY2009 · AI
Structural insights into pandemic and emerging influenza viruses
$822,570Ian A Wilson · Scripps Research Institute, The · R56 · FY2013 · AI